Showing results (61-70 of 903) with videos related to

Sort By:
Pageof 91
Current Pharmaceutical Biotechnology|January 28, 2012
Diastolic heart failure and LV dyssynchronyMario Kasner, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Integrated Blood Pressure Control|September 28, 2011
First-line treatment of hypertension: critical appraisal of potential role of aliskiren and hydrochlorothiazide in a fixed combinationKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular and Cellular Cardiology|September 5, 2009
Immunomodulation and matrix metalloproteinases in viral myocarditisDirk Westermann, Konstantinos Savvatis, Heinz-Peter Schultheiss, et al.
Neuropeptides|December 29, 2009
Kinins in cardiac inflammation and regeneration: insights from ischemic and diabetic cardiomyopathyKonstantinos Savvatis, Dirk Westermann, Heinz-Peter Schultheiss, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 26, 2008
Renin inhibitors, clinical experienceDirk Westermann, Roland Schmieder, Heinz-Peter Schultheiss, et al.
Cardiology Research and Practice|November 20, 2013
Current treatment of heart failure with preserved ejection fraction: should we add life to the remaining years or add years to the remaining life?Jia Li, Peter Moritz Becher, Stefan Blankenberg, et al.
Cardiovascular Therapeutics|February 27, 2020
Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature ReviewRupert Bauersachs, Uwe Zeymer, Jean-Baptiste Brière, et al.
European Heart Journal|July 6, 2019
Management of cardiogenic shock complicating myocardial infarction: an update 2019Holger Thiele, E Magnus Ohman, Suzanne de Waha-Thiele, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|July 31, 2019
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registryUwe Zeymer, Peter Ludman, Nicolas Danchin, et al.
Pageof 91